Maharashtra: Government-Run Blood Banks Slapped Rs 12.72 Lakh In Fines For Neglecting Daily Stock Updates, Reveals RTI Inquiry

Mumbai: The State Blood Transfusion Council imposed a fine of over Rs 12,72,000 on 93 government-run blood banks between December 2022 to April 2023 for not updating the daily blood stock at MahaSBTC and e-raktkosh portal.

The data was revealed through a Right To Information (RTI) filed by activist Chetan Kothari seeking data regarding penalties imposed on blood banks in the last five months. As per the RTI, RN Cooper blood banks tops the list of penalties in terms of violation. Out of a total 121 days, the blood bank has uploaded its blood stock on e-raktkosh only for 25 days.

“The daily stock on e-raktkosh has not been updated 11 times in December 2022, followed by 22 times in January 2023, six times in February, 27 times in March and 30 days in April. All these clearly show that blood banks have not taken GR seriously,” said Kothari.

The public health department had released a government resolution (GR) on December 2 stating that if banks are charging processing fee in excess of the amount stipulated by the National Blood Transfusion Council (NBTC), a penalty of five times the extra processing fee will be levied on the bank.

A senior blood transfusion officer said that often the families of the patients are least aware of the availability of the blood at blood banks. In view of this, the government created the e-blood bank website on which blood banks of all the states have to upload information about their stock. “The basic objective is that whenever a patient needs blood and there is no blood in the blood bank of the hospital, then they can go to thee-blood bank and search in which blood bank the blood is available,” he said.

 

Related Posts

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory